TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$10.87M
As of 2026-03-31
$11.51M
As of 2026-06-30
+9.6%
3-year compound annual growth
+2.5%
5-year compound annual growth
2011-03-31: $6.96M2012-03-31: $8.71M2013-03-31: $8.48M2014-03-31: $8.73M2015-03-31: $2.99M2016-03-31: $3.66M2017-03-31: $4.03M2018-03-31: $3.88M2019-03-31: $3.96M2020-03-31: $8.94M2021-03-31: $9.62M2022-03-31: $10.15M2023-03-31: $8.25M2024-03-31: $8.60M2025-03-31: $9.28M2026-03-31: $10.87M$10.87M
2011-03-31 Total Liabilities (USD) 2026-03-31
Period endedTotal LiabilitiesChange YoYSource filing
2026-03-31$10.87M+17.1%2026-06-16, Balance as of period end
2025-03-31$9.28M+7.9%2026-06-16, Balance as of period end
2024-03-31$8.60M+4.2%2025-06-17, Balance as of period end
2023-03-31$8.25M-18.7%2024-06-17, Balance as of period end
2022-03-31$10.15M+5.4%2023-06-21, Balance as of period end
2021-03-31$9.62M+7.7%2022-07-13, Balance as of period end
2020-03-31$8.94Mn/c2021-07-14, Balance as of period end
2019-03-31$3.96M+2.0%2020-07-10, Balance as of period end
2018-03-31$3.88M-3.7%2019-07-01, Balance as of period end
2017-03-31$4.03M+10.0%2018-06-26, Balance as of period end
2016-03-31$3.66M+22.3%2017-06-28, Balance as of period end
2015-03-31$2.99M-65.7%2016-06-21, Balance as of period end
2014-03-31$8.73M+2.9%2015-06-16, Balance as of period end
2013-03-31$8.48M-2.5%2014-06-30, Balance as of period end
2012-03-31$8.71M+25.0%2013-06-25, Balance as of period end
2011-03-31$6.96Mn/a2012-06-21, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$10.87M+17.1%
Spectral AI, Inc. (MDAI)2025-12-31$27.13M+40.2%
Nephros Inc (NEPH)2025-12-31$3.44M+31.0%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$26.70M+264.3%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$38.48M+0.7%
Profound Medical Corp. (PROF)2025-12-31$11.04M+12.5%
Biotricity Inc. (BTCY)2026-03-31$39.41M+10.5%
Allurion Technologies, Inc. (ALUR)2025-12-31$92.96M-16.1%
Sensus Healthcare, Inc. (SRTS)2025-12-31$4.94M-22.0%

Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗